Trial Profile
A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sargramostim (Primary) ; Zidovudine
- Indications HIV infections; Leucopenia
- Focus Adverse reactions
- Sponsors Sandoz
- 26 Jul 2016 New trial record